Frontiers | Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
Vintage KRAS BRNO Narodni Podnik Czechoslovakian Army Visor Hat SZ 57 NICE SHAPE | eBay
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Notorious KRAS: Taking down cancer researchers' biggest foe
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
JCM | Free Full-Text | KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration
Targeting the KRAS mutation for more effective cancer treatment | MD Anderson Cancer Center
Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein | PNAS
KRAS inhibitors, approved | Nature Cancer
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC) - ScienceDirect
Sotorasib for Lung Cancers with KRAS p.G12C Mutation | NEJM
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
KRAS Biomarker | Colorectal Cancer Alliance
KRAS: feeding pancreatic cancer proliferation: Trends in Biochemical Sciences
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research
Partnership seeks to develop KRAS degraders for cancer therapy | Frederick National Laboratory
Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant | Molecular Pharmaceutics
A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRASG12C inhibitors | PNAS
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Targeting Mutant KRAS for Immunogenic Cell Death Induction: Trends in Pharmacological Sciences
IJMS | Free Full-Text | KRAS-Mutant Non-Small-Cell Lung Cancer: From Past Efforts to Future Challenges
Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells: Cell
Cureus | KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer | Article
Targeting mutated GTPase KRAS in tumor therapies - ScienceDirect
Frontiers | Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies
Targeting KRAS in Lung Cancer: The Past, Present, and Future - ILCN.org (ILCN/WCLC)
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance: Trends in Cancer
